Bipolar Disorder: all 1,637 studies
Page 13 of 17. Open to participants first (258), then studies with results posted, then the rest; newest registration first within each.
- Cytidine- and Creatine-Containing Drug in Treating Bipolar DepressionWithdrawnNCT01543139Phase 2
- Treatment Adherence Enhancement in Bipolar DisorderCompletedNCT01542008Not applicable
- Longitudinal Study of People Presenting for First Treatment of a Mood DisorderStatus unknownNCT01529905
- Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar DepressionCompletedNCT01528839Phase 2/3
- Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type IICompletedNCT01527448Not applicable
- Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian HospitalCompletedNCT01526395Not applicable
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot StudyTerminatedNCT01520350Phase 3
- Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold BipolarCompletedNCT01520129Not applicable
- Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise SpecifiedCompletedNCT01507753Phase 1
- Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary StudyTerminatedNCT01506232
- Intranasal Ketamine In the Treatment of Pediatric Bipolar DisorderTerminatedNCT01504659Phase 2/3
- Risk Factors for AD-Associated Switch to ManiaCompletedNCT01503489
- Evaluation of Generalization Paradigm Patterns Among Different Psychiatric DisordersStatus unknownNCT01501812
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)CompletedNCT01498770
- Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)CompletedNCT01495741
- Early Intervention for Youth at Risk for Bipolar DisorderCompletedNCT01483391Not applicable
- Deep Brain Stimulation for the Treatment of Refractory Bipolar DisorderCompletedNCT01476527Not applicable
- The Effects of Cognitive Remediation on Cognitive Function in Remitted Bipolar Disorder - a Proof of Concept StudyCompletedNCT01457235Not applicable
- An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar DisorderCompletedNCT01455961
- Heart Rate Variability of Patients With Bipolar Disorder in Subsyndromal Depressive PhaseCompletedNCT01455038
- General Practice Research Database Seroquel XR Safety StudyCompletedNCT01447082
- The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes)CompletedNCT01446406Not applicable
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With SchizophreniaCompletedNCT01431092Phase 4
- Special Drug Use Investigation for LAMICTAL BipolarCompletedNCT01428518
- Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar DepressionCompletedNCT01403662Phase 3
- Female Experiences and Brain ActivityCompletedNCT01395160
- IBIS: Italian Burden of Illness on Schizophrenia & Bipolar DisorderCompletedNCT01392482
- The Influence of the Menstrual Cycle on Lithium and Sertraline Blood LevelsCompletedNCT01385709
- Neurophysiological Studies in Schizophrenia and Psychiatric DisordersCompletedNCT01384604
- A Study of LY2979165 in Healthy SubjectsCompletedNCT01383967Phase 1
- Clinical Risk State for Bipolar Disorder in AdolescentsStatus unknownNCT01383915
- The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription BehavioursCompletedNCT01377896
- Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar DisorderWithdrawnNCT01372722Phase 2/3
- The Effect of Omega-3 Polyunsaturated Fatty Acids in the Treatment and Prevention of Relapse of Bipolar DisorderCompletedNCT01371383Not applicable
- Functional Remediation for Bipolar DisorderCompletedNCT01370668Not applicable
- Illness Management and Recovery (IMR) in Danish Community Mental Health CentresCompletedNCT01361698Not applicable
- Pioglitazone and Quetiapine XR Pharmacogenetic StudyCompletedNCT01342380
- PHARMO Institute Seroquel Safety StudyCompletedNCT01342120
- Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)CompletedNCT01339598Phase 1
- Benefits Management for People With Psychiatric DisabilitiesCompletedNCT01329393Phase 1
- Involvement of the Sodium Pump and Endogenous Digitalis-like Compounds in Bipolar DisorderCompletedNCT01322113
- Dental Status of Patients With Severe Mental IllnessCompletedNCT01315509
- Feeling of Being in Control of One's Own ActionCompletedNCT01312649Not applicable
- Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ DepressionCompletedNCT01303601Phase 4
- Prospective Metabolic Monitoring of Youth and Adults With Bipolar DisorderCompletedNCT01282281
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)CompletedNCT01272531
- To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II DisorderCompletedNCT01263548
- Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-upCompletedNCT01255982
- A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy VolunteersCompletedNCT01248052Phase 1
- Relative Effectiveness of Schizophrenia Therapy StudyCompletedNCT01245348
- Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental IllnessCompletedNCT01244854Not applicable
- European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic EpisodesCompletedNCT01239589
- Peroxisomal Defects and Familial Risk for Bipolar DisorderCompletedNCT01237379
- Genetic Association Study Between GAD1 and Reelin Polymorphisms and GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy Controls: SPECGENE PROJECTStatus unknownNCT01237158
- The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic TherapyStatus unknownNCT01215383
- Neurophysiologic Changes in Patients With Bipolar DepressionStatus unknownNCT01213121Phase 4
- Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by AlcoholismWithdrawnNCT01211704Phase 4
- Emotion Regulation Group Therapy for Bipolar DisorderCompletedNCT01207505Not applicable
- A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.CompletedNCT01202604
- Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar DisorderCompletedNCT01197846Phase 3
- Duration of Untreated Psychosis (DUP) and Pathways to Care in NordlandCompletedNCT01196858
- Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451CompletedNCT01196676Phase 1
- Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset PsychosisCompletedNCT01196286Not applicable
- The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute ManiaCompletedNCT01191918Phase 4
- Bipolar Disorder With Alcoholism in Han ChineseStatus unknownNCT01188395
- Add-on Dextromethorphan in Bipolar DisordersCompletedNCT01188265Phase 3
- Series Studies of Bipolar Disorder-Valproate add-on MemantineCompletedNCT01188148Phase 2/3
- Reduction of Cardiovascular Risk in Severe Mental IllnessStatus unknownNCT01182012Phase 4
- Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health OrganizationsCompletedNCT01181960
- Cognitive-Behavior Therapy for Young Adults With Bipolar DisorderCompletedNCT01176825Phase 1
- Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.CompletedNCT01166425Phase 2/3
- MAPS Group Therapy Model for Bipolar DisorderCompletedNCT01152034Not applicable
- CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar IllnessCompletedNCT01149551
- Patient Guided Psychiatric AdmissionsCompletedNCT01133587Not applicable
- Adjunctive Lisdexamfetamine (LDX) in Bipolar DepressionTerminatedNCT01131559Phase 3
- Mindfulness-Based Cognitive Behavior Therapy for Bipolar DisorderCompletedNCT01126827Not applicable
- Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)WithdrawnNCT01124877Phase 3
- Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)WithdrawnNCT01117220Phase 3
- Insulin Resistance in Patients With Major DepressionCompletedNCT01106313
- A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective DisorderCompletedNCT01094249Phase 1
- Efficacy Study of Lisdexamfetamine to Treat Bipolar DepressionTerminatedNCT01093963Phase 3
- Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar DisorderCompletedNCT01093937Not applicable
- Calling for Care: Cell Phones for Mood Telemetry in TeensCompletedNCT01083823Not applicable
- Safety Study of Depakote Versus Lithium in African Americans With Bipolar DisorderWithdrawnNCT01075126Phase 4
- Study of the Clinical Management of Bipolar DiseaseCompletedNCT01062607
- Interpersonal and Social Rhythm Therapy Enter the Brief Title for Protocol IRB 09-003781>CompletedNCT01037283Not applicable
- Management of Index Episode in Patients With Bipolar Disorder Treated by Seroquel XRCompletedNCT01029145
- Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionCompletedNCT01028196
- Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a ChildCompletedNCT01012180
- Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following PsychosisCompletedNCT01003132Not applicable
- Juvenile Bipolar Disorder Outpatient ProgramStatus unknownNCT01000402Phase 4
- Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar DisorderCompletedNCT00999765
- Biomarkers for Bipolar Disorder: Chaperones and Reticulum Endoplasmatic Stress Response CHAP´s StudySuspendedNCT00994630
- Sleep Disturbance and Bipolar DisorderCompletedNCT00993850Phase 3
- Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin ReleaseCompletedNCT00988949Phase 1
- A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective DisordersCompletedNCT00986336Phase 1
- A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder PatientsCompletedNCT00986128Phase 1
- Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar DisorderCompletedNCT00980863Not applicable
- Pediatric Bipolar Disorder Study at UCLACompletedNCT00961935